Health care industry
Function Health buys Ezra, launches full-body scan for a third of the price
Jonathan Swerdlin, co-founder and CEO of Function Health. Courtesy of Function Health. Blood testing startup Function Health on Monday announced the acquisition of full-body MRI scanning company Ezra and launched a new, 22-minute scan for $499. Function offers a $499 annual subscription where members complete more than 160 blood tests and track their results over […]
Read More
Hims & Hers brings former Amazon executive into C-suite
Bringing nearly 20 years of global experience at Amazon, Nader Kabbani is joining the executive leadership team to help the company further innovate on the delivery of affordable, seamless personalized care in the U.S. and globally. Courtesy: Hims & Hers Hims & Hers Health on Monday announced Nader Kabbani, a former Amazon executive who helped […]
Read More
From ‘Cockroach Award’ to the Big Board: Hinge Health’s unlikely path to IPO
Hinge Health co-founders Gabriel Mecklenburg (left) and Daniel Perez (right). Courtesy of Hinge Health At digital physical therapy startup Hinge Health, CEO Daniel Perez used to recognize hard-working employees with the “Cockroach Award,” a distinction that brought with it a “cockroach squad” t-shirt and a cash payout. References to the insect were abundant at the […]
Read More
CVS to boost access to Novo Nordisk’s weight loss treatment Wegovy for patients on its drug plans
The “Wegovy” brand slimming syringe is sold in the Achat pharmacy in Mitte. The “Wegovy” slimming syringe has been available in Germany for a year. Jens Kalaene | Picture Alliance | Getty Images CVS Health on Thursday said it will significantly expand access to the blockbuster weight loss drug Wegovy for patients covered by its […]
Read More
Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer treatment deal
Eli Lilly on Thursday reported first-quarter revenue and earnings that topped estimates as demand for its weight loss and diabetes drugs soared, but lowered its full-year profit guidance due to charges related to a recent cancer treatment deal. The pharmaceutical giant now expects its adjusted fiscal 2025 earnings to come in between $20.78 and $22.28 […]
Read More
Eli Lilly CEO says company can help ‘respond’ to national security concerns around essential drugs as tariffs loom
CEO of Eli Lilly and Company David Ricks speaks at the Economic Club of New York on March 12, 2024 in New York City. Spencer Platt | Getty Images Eli Lilly CEO Dave Ricks on Thursday said the drugmaker can help “respond” to national security concerns around cheaper essential medicines as pharmaceutical-specific tariffs loom. The […]
Read More
CVS tops estimates, hikes guidance as insurance business shows some improvement
CVS Pharmacy logo is seen in Washington DC, United States on July 9, 2024. Jakub Porzycki | Nurphoto | Getty Images CVS Health on Thursday reported first-quarter earnings and revenue that topped estimates and hiked its guidance, as its troubled insurance business showed some improvement during the period. The company now expects full-year adjusted earnings […]
Read More
Epic Systems expands EHR market share lead over Oracle Health
The eponymous sign outside Epic headquarters in Verona, Wisconsin. Source: Yiem via Wikipedia CC Epic Systems, the biggest electronic health records (EHR) vendor, notched its largest ever net gain in hospital market share on record in 2024, widening its lead over rival Oracle, according to a report from Klas Research on Wednesday. Epic added a […]
Read More
Teladoc buys mental health company UpLift to help boost struggling BetterHelp unit
Teladoc Health Inc. signage on the floor of the New York Stock Exchange on Dec. 31, 2024. Michael Nagle | Bloomberg | Getty Images Virtual care provider Teladoc Health, which has seen its market value plummet over the past five years, said Wednesday that it acquired mental health company UpLift for $30 million in cash. […]
Read More
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom
Jgi/jamie Grill | Tetra Images | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Tariff threats — and efforts to get into President Donald Trump’s good graces — are fueling a new wave […]
Read More